QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.

about

QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.

Item

http://www.wikidata.org/entity/Q44395826

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@en

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@nl

type

Item

label

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@en

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@nl

prefLabel

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@en

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@nl

P1476

QuantiFERON testing for cell-m ...... acept and other DMARD therapy.

@en

P2093

Anthony S Russell

http://www.w3.org/2001/XMLSchema#string

Atul Humar

http://www.w3.org/2001/XMLSchema#string

Deepali Kumar

http://www.w3.org/2001/XMLSchema#string

Marla F Dos Santos

http://www.w3.org/2001/XMLSchema#string

P2860

Cell-mediated immunity in rheumatoid arthritis.

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects.

Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis.

Costimulation blockade in rheumatic diseases: where we are?

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.

NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

P304

1657-1659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-013-2298-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luiz F Lisboa

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23754242

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus